Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Cellebrite DI stock price, quote, forecast and news

CLBT
IL0011794802

Price

16.85
Today +/-
-0.33
Today %
-2.14 %
P

Cellebrite DI stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Cellebrite DI stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Cellebrite DI stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Cellebrite DI stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Cellebrite DI's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Cellebrite DI Stock Price History

DateCellebrite DI Price
9/27/202416.85 undefined
9/26/202417.22 undefined
9/25/202416.63 undefined
9/24/202416.86 undefined
9/23/202417.30 undefined
9/20/202417.40 undefined
9/19/202417.44 undefined
9/18/202417.25 undefined
9/17/202417.46 undefined
9/16/202417.52 undefined
9/13/202417.51 undefined
9/12/202416.96 undefined
9/11/202416.64 undefined
9/10/202416.51 undefined
9/9/202416.42 undefined
9/6/202416.34 undefined
9/5/202416.85 undefined
9/4/202416.84 undefined
9/3/202416.95 undefined
8/30/202417.06 undefined

Cellebrite DI Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Cellebrite DI, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cellebrite DI from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cellebrite DI’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Cellebrite DI. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Cellebrite DI’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Cellebrite DI’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cellebrite DI’s growth potential.

Cellebrite DI Revenue, EBIT and net profit per share

DateCellebrite DI RevenueCellebrite DI EBITCellebrite DI Net Income
2028e662.9 M undefined147.19 M undefined159.18 M undefined
2027e586.3 M undefined127.09 M undefined133.71 M undefined
2026e557.7 M undefined116.62 M undefined118.15 M undefined
2025e470.74 M undefined92.64 M undefined78.83 M undefined
2024e402.11 M undefined73.05 M undefined86.66 M undefined
2023325.11 M undefined33.24 M undefined-81.1 M undefined
2022270.7 M undefined1 M undefined116.1 M undefined
2021246.2 M undefined25.6 M undefined70.4 M undefined
2020194.9 M undefined9.2 M undefined-9.3 M undefined
2019171.9 M undefined-1.5 M undefined-10 M undefined

Cellebrite DI Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201920202021202220232024e2025e2026e2027e2028e
171194246270325402470557586662
-13.4526.809.7620.3723.6916.9218.515.2112.97
79.5380.9382.5281.1183.38-----
13615720321927100000
-19251337392116127147
-0.584.6410.160.3710.1518.1619.5720.8321.6722.21
-10-970116-818678118133159
--10.00-877.7865.71-169.83-206.17-9.3051.2812.7119.55
188.5188.5188.5195.4190.1500000
----------
Details

Keystats

ⓘ

Revenue and Growth

The Cellebrite DI Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Cellebrite DI is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20192020202120222023
         
200.3237.6181.6139264.23
46.669.573.185.883.42
00000
44.86.510.29.94
11.112.41260.964.5
262324.3273.2295.9422.08
14.816.116.832.930.16
00022.128.86
00000
06.611.211.310.59
09.526.826.826.83
3.57.911.814.214.37
18.340.166.6107.3110.8
280.3364.4339.8403.2532.89
         
101.2101.2000
25.534.2-153.1-125.6-84.9
32.628.378.4199.2118.14
0.81.31.40.31.05
00000
160.1165-73.373.934.3
5.44.79.54.653.13
21.739.142.544.745.24
72.1115.5134.5158.4200.3
00000
00000
99.2159.3186.5207.7298.67
00000
00000
2140226.6121.7244.85
2140226.6121.7244.85
120.2199.3413.1329.4543.52
280.3364.3339.8403.3577.82
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Cellebrite DI provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Cellebrite DI's financial health and stability.

Assets

Cellebrite DI's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Cellebrite DI must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Cellebrite DI after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Cellebrite DI's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20192020202120222023
-1571120-81
457910
-1-2-1-25
24920-238
2515-54-90148
00000
3231910
16663620102
-6-6-8-9-7
-46-645-91-22
-40053-82-14
00000
00000
100121321
75-8-681321
002900
-25-10-10000
445212-58101
9.9260.3327.9411.4994.14
00000

Cellebrite DI stock margins

The Cellebrite DI margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cellebrite DI. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cellebrite DI.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Cellebrite DI's sales revenue. A higher gross margin percentage indicates that the Cellebrite DI retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Cellebrite DI's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Cellebrite DI's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cellebrite DI's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cellebrite DI. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cellebrite DI's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Cellebrite DI Margin History

Cellebrite DI Gross marginCellebrite DI Profit marginCellebrite DI EBIT marginCellebrite DI Profit margin
2028e83.63 %22.2 %24.01 %
2027e83.63 %21.68 %22.81 %
2026e83.63 %20.91 %21.18 %
2025e83.63 %19.68 %16.75 %
2024e83.63 %18.17 %21.55 %
202383.63 %10.22 %-24.95 %
202281.23 %0.37 %42.89 %
202182.74 %10.4 %28.59 %
202080.55 %4.72 %-4.77 %
201979.12 %-0.87 %-5.82 %

Cellebrite DI Stock Sales Revenue, EBIT, Earnings per Share

The Cellebrite DI earnings per share therefore indicates how much revenue Cellebrite DI has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cellebrite DI earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cellebrite DI's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cellebrite DI’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cellebrite DI's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Cellebrite DI Revenue, EBIT and net profit per share

DateCellebrite DI Sales per ShareCellebrite DI EBIT per shareCellebrite DI Earnings per Share
2028e3.19 undefined0 undefined0.77 undefined
2027e2.82 undefined0 undefined0.64 undefined
2026e2.68 undefined0 undefined0.57 undefined
2025e2.26 undefined0 undefined0.38 undefined
2024e1.93 undefined0 undefined0.42 undefined
20231.71 undefined0.17 undefined-0.43 undefined
20221.39 undefined0.01 undefined0.59 undefined
20211.31 undefined0.14 undefined0.37 undefined
20201.03 undefined0.05 undefined-0.05 undefined
20190.91 undefined-0.01 undefined-0.05 undefined

Cellebrite DI business model

Cellebrite DI Ltd is an Israeli company that was founded in 1999 and is headquartered in Petah Tikva. The company specializes in the development and marketing of mobile data extraction and analysis tools, and has gained a reputation as a market leader in the field of forensic data analysis. Cellebrite DI is one of the most popular companies on Eulerpool.com.

Cellebrite DI SWOT Analysis

Strengths

Cellebrite DI Ltd is known for its innovative technology solutions in the field of digital forensics and mobile data extraction. This strength allows the company to stay on top of industry trends and provide cutting-edge solutions to its customers.

With a long history in the industry and a track record of successful partnerships and projects, Cellebrite DI Ltd has built a strong reputation as a reliable and trustworthy provider of digital investigation tools and services. This reputation gives the company a competitive edge in the market.

Cellebrite DI Ltd has a wide international presence, with offices and customers in various countries. This global footprint allows the company to cater to diverse markets and leverage its expertise across different regions, creating growth opportunities and a larger customer base.

Weaknesses

Cellebrite DI Ltd heavily relies on demand from law enforcement agencies for its products and services. Any fluctuations or changes in government budgets or regulations impacting these agencies could potentially affect the company's revenue and growth prospects.

The nature of Cellebrite DI Ltd's products and services requires a high level of technical expertise for their implementation and effective usage. This can pose a challenge for customers who may need to invest in training or hiring specialized personnel to fully utilize the solutions offered by the company.

Opportunities

The digital forensics market is expected to grow rapidly in the coming years due to the increasing need for digital evidence in criminal investigations and legal proceedings. This presents an opportunity for Cellebrite DI Ltd to expand its customer base and revenues by capitalizing on this growing demand.

Cellebrite DI Ltd can explore opportunities to expand its offerings beyond law enforcement agencies and into sectors such as cybersecurity, corporate investigations, and e-discovery. This diversification can open up new revenue streams and increase the company's market presence.

Threats

The digital forensics industry is highly competitive, and Cellebrite DI Ltd faces competition from both established players and emerging start-ups. To maintain its market position, the company needs to continuously innovate and differentiate its offerings from competitors.

Increasing scrutiny and regulations related to privacy and data protection can impact Cellebrite DI Ltd's operations and the use of its technology. Compliance with evolving regulatory frameworks becomes crucial to avoid legal and reputational risks.

Cellebrite DI Revenue by Segment

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Cellebrite DI Revenue by Segment

Segmente202320222021
Subscription services--120.89 M USD
Term-license--62.43 M USD
Perpetual license and other--34.17 M USD
Professional services--28.76 M USD
Subscription Services209.75 M USD--
License and Service--183.32 M USD
Subscription services-153.47 M USD-
Term-Licenses70.66 M USD--
Term-license-62.49 M USD-
Professional services-33.32 M USD-
Professional Services31.14 M USD--
Perpetual license and related-21.37 M USD-
Other non-recurring13.56 M USD--

Cellebrite DI Revenue by Region

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Cellebrite DI Revenue by Segment

DateAmericaAmericasAPACAsia PacificEMEA
2023-172.15 M USD-40.71 M USD112.25 M USD
2022141.92 M USD-35.98 M USD-92.75 M USD
2021126.93 M USD-30.88 M USD-88.44 M USD

Cellebrite DI Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Cellebrite DI historical P/E ratio, EBIT, and P/S ratio.

Cellebrite DI shares outstanding

The number of shares was Cellebrite DI in 2023 — This indicates how many shares 190.155 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cellebrite DI earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cellebrite DI's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cellebrite DI’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cellebrite DI's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Cellebrite DI.

Cellebrite DI latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20240.05 0.1  (86.57 %)2024 Q2
3/31/20240.06 0.08  (40.11 %)2024 Q1
12/31/20230.06 0.11  (85.81 %)2023 Q4
9/30/20230.05 0.1  (114.43 %)2023 Q3
6/30/20230.02 0.05  (110.08 %)2023 Q2
3/31/20230.02 0.04  (74.67 %)2023 Q1
12/31/20220.04 0.08  (96.08 %)2022 Q4
9/30/20220.02 0.01  (-56.33 %)2022 Q3
6/30/20220.03 0  (-100 %)2022 Q2
3/31/20220.02 0.01  (-56.33 %)2022 Q1
1
2

Cellebrite DI list of shareholders

%
Name
Stocks
Change
Date
6.43382 % True Wind Capital Management, L.P.13,387,500012/31/2023
45.94277 % Sun Corp95,597,718012/31/2023
3.40550 % Clal Insurance Enterprises Holdings Ltd.7,086,158514,85812/31/2023
2.37215 % Carmil (Yossi)4,935,97168,99412/31/2023
10.13442 % IGP Investments GPLP LP21,087,692-11,543,80012/31/2023
1.94893 % Phoenix Investment and Finances Ltd4,055,330-1,968,76612/31/2023
1.78114 % Nine Ten Capital Management LLC3,706,1982,639,59612/31/2023
1.73288 % Morgan Stanley & Co. LLC3,605,7701,275,18412/31/2023
1.55732 % Crosslink Capital, Inc.3,240,48044,52012/31/2023
1.37364 % Greenhaven Road Investment Management, L.P.2,858,268-314,33912/31/2023
1
2
3
4
5
...
10

Cellebrite DI Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Axon Enterprise Stock
Axon Enterprise
SupplierCustomer0,250,730,880,830,93-
Panasonic Holdings Stock
Panasonic Holdings
SupplierCustomer0,10-0,300,100,610,59-
Cyber Sec 1 Stock
Cyber Sec 1
SupplierCustomer-0,060,100,820,500,60-
Matrix IT Stock
Matrix IT
SupplierCustomer-0,380,820,800,500,89-
Suncorp Stock
Suncorp
SupplierCustomer-0,480,180,710,780,88-
1

Most common questions regarding Cellebrite DI

What values and corporate philosophy does Cellebrite DI represent?

Cellebrite DI Ltd represents a set of values and a corporate philosophy that drives its operations and services. The company is committed to excellence, innovation, and customer satisfaction. With a focus on providing cutting-edge digital intelligence solutions, Cellebrite DI Ltd aims to empower law enforcement agencies, government entities, and enterprises in tackling complex digital investigations. They strive to uphold the highest standards of integrity, transparency, and accountability in their work. By continually adapting to evolving technologies and delivering efficient solutions, Cellebrite DI Ltd strives to be a trusted leader in the digital intelligence industry.

In which countries and regions is Cellebrite DI primarily present?

Cellebrite DI Ltd is primarily present in various countries and regions worldwide. These include the United States, Israel (where its headquarters are located), Europe, Asia Pacific, and Latin America.

What significant milestones has the company Cellebrite DI achieved?

Cellebrite DI Ltd, a leading digital intelligence company, has achieved significant milestones in its remarkable journey. The company has revolutionized the field of digital forensics and mobile data extraction. Cellebrite DI Ltd has gained recognition for its cutting-edge technology, enabling law enforcement agencies and businesses to unlock crucial evidence from mobile devices. The company has expanded its global presence, catering to customers in over 150 countries. Through continuous innovation and strategic partnerships, Cellebrite DI Ltd has become a trusted name in the industry. Its dedication to excellence and commitment to providing reliable solutions have propelled the company forward, earning it a prominent position in the digital intelligence landscape.

What is the history and background of the company Cellebrite DI?

Cellebrite DI Ltd is a renowned telecommunications company with a rich history and extensive background. Established in 1999, Cellebrite DI Ltd has gained recognition as a global leader in digital intelligence solutions. The company specializes in providing advanced mobile data forensics and mobile lifecycle solutions. Over the years, Cellebrite DI Ltd has developed cutting-edge technologies that assist law enforcement agencies, government organizations, and enterprises in analyzing digital data, extracting valuable insights, and solving complex cases. With its innovative software and hardware solutions, Cellebrite DI Ltd empowers its clients to efficiently tackle challenges in the digital world. Through continuous advancements, the company remains at the forefront of the industry, delivering exceptional solutions worldwide.

Who are the main competitors of Cellebrite DI in the market?

Cellebrite DI Ltd faces competition from various companies in the market. Some of its main competitors include MSAB, Oxygen Forensics, BlackBag Technologies, and AccessData. These companies also offer digital intelligence and forensic solutions similar to Cellebrite DI Ltd. Nonetheless, Cellebrite DI Ltd distinguishes itself through its cutting-edge technologies and comprehensive range of products and services. With its strong market presence and continuous innovation, Cellebrite DI Ltd remains a leading player in the digital intelligence solutions industry, maintaining a competitive edge over its rivals.

In which industries is Cellebrite DI primarily active?

Cellebrite DI Ltd is primarily active in the technology and cybersecurity industries.

What is the business model of Cellebrite DI?

The business model of Cellebrite DI Ltd revolves around digital intelligence solutions and services. Cellebrite DI Ltd specializes in providing a wide range of capabilities to collect, analyze, and interpret data from digital devices. With its advanced technologies, the company helps law enforcement agencies, intelligence organizations, and enterprises to combat digital crime, conduct digital investigations, and enhance cybersecurity. By offering innovative solutions, Cellebrite DI Ltd enables its clients to extract valuable insights and evidence from mobile devices, cloud sources, and social media platforms. Through its comprehensive suite of products, Cellebrite DI Ltd aims to empower its customers with actionable intelligence in the rapidly evolving digital landscape.

What is the P/E ratio of Cellebrite DI 2024?

The Cellebrite DI P/E ratio is 36.97.

What is the P/S ratio of Cellebrite DI 2024?

The Cellebrite DI P/S ratio is 7.97.

What is the AlleAktien quality score of Cellebrite DI?

The AlleAktien quality score for Cellebrite DI is 4/10.

What is the revenue of Cellebrite DI 2024?

The expected Cellebrite DI revenue is 402.11 M USD.

How high is the profit of Cellebrite DI 2024?

The expected Cellebrite DI profit is 86.66 M USD.

What is the business model of Cellebrite DI

Cellebrite DI is a company specializing in digital forensics and mobile data collection. It offers software-based solutions for mobile forensics, digital forensic labs, mobile data collection, and device unlocking for law enforcement agencies, military and government agencies, as well as businesses and lawyers. The company was founded in Israel in 1999 and is a subsidiary of Sun Corporation, employing over 700 employees worldwide. Cellebrite's products can be divided into three main areas: mobile forensics, digital forensic labs, and mobile data collection and unlocking. They also provide additional services such as training, technical support, and consulting. Overall, Cellebrite DI is a leading company in the field of digital forensics and mobile data collection, aiming to support law and order globally through innovative technologies.

What is the Cellebrite DI dividend?

Cellebrite DI pays a dividend of 0 USD distributed over payouts per year.

How often does Cellebrite DI pay dividends?

The dividend cannot currently be calculated for Cellebrite DI or the company does not pay out a dividend.

What is the Cellebrite DI ISIN?

The ISIN of Cellebrite DI is IL0011794802.

What is the Cellebrite DI ticker?

The ticker of Cellebrite DI is CLBT.

How much dividend does Cellebrite DI pay?

Over the past 12 months, Cellebrite DI paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cellebrite DI is expected to pay a dividend of 0 USD.

What is the dividend yield of Cellebrite DI?

The current dividend yield of Cellebrite DI is .

When does Cellebrite DI pay dividends?

Cellebrite DI pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cellebrite DI?

Cellebrite DI paid dividends every year for the past 0 years.

What is the dividend of Cellebrite DI?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cellebrite DI located?

Cellebrite DI is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von Cellebrite DI kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cellebrite DI from 9/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Cellebrite DI pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Cellebrite DI in the year 2023?

In the year 2023, Cellebrite DI distributed 0 USD as dividends.

In which currency does Cellebrite DI pay out the dividend?

The dividends of Cellebrite DI are distributed in USD.

All fundamentals about Cellebrite DI

Our stock analysis for Cellebrite DI Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cellebrite DI Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.